Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing prevalence of hypertension
3.2.1.2 Advances in hypertensive drug development and formulations
3.2.1.3 Growing awareness about the risks of hypertension
3.2.1.4 Integration of digital health solutions in treatment strategies
3.2.2 Industry pitfalls & challenges
3.2.2.1 Poor medication adherence during antihypertensive treatments
3.2.2.2 Presence of stringent regulations
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Patent analysis
3.7 Gap analysis
3.8 Future market trends
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy outlook
Chapter 5 Market Estimates and Forecast, By Therapy, 2021 – 2034 ($ Mn)
5.1 Key trends
5.2 Diuretics
5.2.1 Thiazide diuretics
5.2.2 Loop diuretics
5.2.3 Potassium-sparing diuretics
5.3 ACE inhibitors
5.4 Angiotensin receptor blockers
5.5 Beta blockers
5.5.1 Beta-1 selective
5.5.2 Intrinsic sympathomimetic
5.6 Calcium channel blockers
5.7 Renin inhibitors
5.8 Alpha-blockers
5.9 Vasodilators
5.10 Other therapies
Chapter 6 Market Estimates and Forecast, By Drug Type, 2021 – 2034 ($ Mn)
6.1 Key trends
6.2 Primary hypertension
6.3 Secondary hypertension
Chapter 7 Market Estimates and Forecast, By Route of Administration, 2021 – 2034 ($ Mn)
7.1 Key trends
7.2 Oral
7.3 Injectables
7.4 Other routes of administration
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 – 2034 ($ Mn)
8.1 Key trends
8.2 Retail pharmacy
8.3 Hospital pharmacy
8.4 Online pharmacy
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
Chapter 10 Company Profiles
10.1 AbbVie
10.2 AstraZeneca
10.3 Bayer AG
10.4 Boehringer Ingelheim International GmbH
10.5 Daiichi Sankyo Company
10.6 Johnson & Johnson Services
10.7 Lupin
10.8 Merck & Co
10.9 Noden Pharma DAC
10.10 Novartis AG
10.11 Pfizer
10.12 Sanofi
10.13 Sun Pharmaceutical Industries
10.14 Takeda Pharmaceutical
10.15 Torrent Pharmaceuticals
